oxybutynin has been researched along with Hay Fever in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The emedastine patch was developed in Japan as the first transdermal drug delivery system of emedastine difumarate for allergic rhinitis." | 2.87 | Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinit ( Akiyama, K; Kobayashi, S; Okubo, K; Tanaka, Y; Terahara, T; Uchida, E, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okubo, K | 1 |
| Uchida, E | 1 |
| Terahara, T | 1 |
| Akiyama, K | 1 |
| Kobayashi, S | 1 |
| Tanaka, Y | 1 |
| Senti, G | 1 |
| von Moos, S | 1 |
| Tay, F | 1 |
| Graf, N | 1 |
| Johansen, P | 1 |
| Kündig, TM | 1 |
2 trials available for oxybutynin and Hay Fever
| Article | Year |
|---|---|
Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinit
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Benzimidazoles; Double-Blind Method; Female; Humans; | 2018 |
Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.
Topics: Adolescent; Adult; Aged; Conjunctivitis, Allergic; Desensitization, Immunologic; Double-Blind Method | 2015 |